Earnings Call · Q4 FY2023·2024-02-26

Q4 23EPS +100.00%*·Rev n/aQ3 23EPS +88.89%·Rev n/aQ2 23EPS -18.18%·Rev n/aQ1 23EPS -20.00%·Rev n/a⚠ consensus missing

Theravance Biopharma, Inc. TBPH

Rick Winningham — President and Chief Executive Officer

Aine Miller — Chief Medical Officer

Rhonda Farnum — Senior Vice President, Commercial

Aziz Sawaf — Chief Financial Officer

+5.0%1d on move date+4.8% vs SPY3d+2.6%5d−1.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TBPH calls or request research access.

More TBPH calls Browse calls Request research access